A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma
A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma have?
A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma has 27 citations in the OpenAlex counts ScholarIQ stores.
When was A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma published?
A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma has 2020 year in the ScholarIQ index.
What is the open-access status of A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma?
A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma?
The DOI for A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma is on the source record.
What is the PMID of A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma?
The PMID for A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma is on the source record.
What is the OpenAlex record for A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma?
The OpenAlex for A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma is on the source record.